180 likes | 192 Views
Trends in the incidence of renal failure in Australia. John Stewart, Margaret McCredie, Stephen McDonald. Background. The patterns of incident ESRD have changed substantially over recent years A variety of factors might contribute to this Altered disease incidence Altered disease outcomes
E N D
Trends in the incidence of renal failure in Australia John Stewart, Margaret McCredie, Stephen McDonald
Background • The patterns of incident ESRD have changed substantially over recent years • A variety of factors might contribute to this • Altered disease incidence • Altered disease outcomes • Altered referral and selection bias • Changes in the underlying popuation ANZDATA Registry, ANZSN 2003
Methods • Treated ESRD (ANZDATA), Australia only • Only 90+ day survivors • Indirect standardisation to Australian population values (ABS) • Changes examined in 3 groups • Age • Disease • Country of birth ANZDATA Registry, ANZSN 2003
Age at entry B A New patients per year, 1971-2001, Australia, treated ESRD only ANZDATA Registry, ANZSN 2003
95% CI Rate ratio Age-specific changes 15 3 Non-indigenous 10 Indigenous 2.5 5 2 Rate ratio Rate ratio 2 1.5 1 1 .5 0-14 15-24 25-34 35-44 45-54 55-64 65+ 0-14 15-24 25-34 35-44 45-54 55-64 65+ Age group Age group Incidence rate ratios for 1992-2001 compared to 1982-1991 ANZDATA Registry, ANZSN 2003
Diseases over time • The changes in disease incidence rates from the period 1982-1991 to 1992-2001 was examined, stratified by age groups • Changes in most diseases are similar to the overall pattern, except • Diabetes • Hypertension / arteriopathy • Analgaesic nephropathy ANZDATA Registry, ANZSN 2003
95% CI Rate ratio Diabetic nephropathy 15 15 Type 1 diabetes Type 2 diabetes 10 10 5 5 Rate ratio Rate ratio 2 2 1 1 .5 .5 25-34 35-44 45-54 55-64 65+ 35-44 45-54 55-64 65+ Age group Age group ANZDATA Registry, ANZSN 2003
95% CI Rate ratio Hypertension / analgaesic 10 Analgaesic Hypertension / vascular 2 5 1 Rate ratio Rate ratio .5 2 1 .2 .1 .5 35-44 45-54 55-64 65+ 45-54 55-64 65+ Age group Age group ANZDATA Registry, ANZSN 2003
Place of birth • Country of birth grouped by region • Australia, British Isles, Southern Europe, Rest of Europe, Middle East, Indian sub-continent, East / South East Asia, Pacific Island • Other than Pacific Island (23% Fijian Indians) and Middle East (15% European) there was little difference between country of birth and racial origin. • All RRT patients who survived 90 days, 1993-2001 ANZDATA Registry, ANZSN 2003
S. Europe 1 1 1.4 British Isles .9 1.2 .8 .8 1 .7 Rate ratio Rate ratio Rate ratio .6 .8 .6 Rest of Europe .5 .6 .4 15-44 45-64 65 & over 15-44 45-64 65 & over 15-44 45-64 65 & over Age (years) Age (years) Age (years) Indian sub-cont East/SE Asia Mid East 3 2.5 2.5 2 2.5 2 1.5 2 Rate ratio Rate ratio Rate ratio 1 1.5 1.5 1 1 .5 15-44 45-64 65 & over 15-44 45-64 65 & over 15-44 45-64 65 & over Age (years) Age (years) Age (years) Incidence by country of birth ANZDATA Registry, ANZSN 2003
Population Australian population and Australian ESRD patients, 1993-2001, by country of birth ANZDATA Registry, ANZSN 2003
Specific diseases - 1 • Glomerulonephritis in 45-64 year group Country of birthRate ratio British Isles 0.8 [0.7-1.0] S.Europe 1.6 [1.4-1.8] Rest of Europe 0.7 [0.6-0.9] Middle Eastern 2.1 [1.5-2.8] Indian subcontinent 1.1 [0.6-1.8] East/SE Asia 2.2 [1.8-2.7] Pacific Islands 3.9 [2.5-5.9] ANZDATA Registry, ANZSN 2003
Specific diseases – 2 • Hypertension / arteriopathic / renovascular disease among 65+ year group Country of birthRate ratio British Isles 0.9 [0.7-1.1] S. Europe 0.9 [0.8-1.2] Rest of Europe 1.0 [0.8-1.2] Middle Eastern 1.6 [1.0-2.5] Indian subcontinent 2.0 [1.2-3.2] East/SE Asia 1.5 [1.0-2.0] ANZDATA Registry, ANZSN 2003
Issues • Selection bias • ANZDATA only collects treated ESRD • Most applicable to older age group • Will change over time • Competing risks • Patients may now be surviving to end-stage whereas previously they did not • Lead-time bias • Lessening level of creatinine at entry • Effect on survival analyses • Changing demography • Progressive increase in proportion of populations of Asian / Aboriginal / Maori / PI racial origin • Progressive ageing of the population. ANZDATA Registry, ANZSN 2003
Issues 2 • Classification bias • Is the increase in type 1 diabetes actually type 2 in young people? • Changes in disease prevalence • Increasing population prevalence of diabetes • Changes in disease behaviours • ?beneficial effect of treatments • ACE inhibitors may reduce the number of diabetics reaching end-stage • But they may also affect the competing risk of cardiovascular disease ANZDATA Registry, ANZSN 2003
Where to? • More detailed examination of trends in recent years, and types of GN • Comparison of these changes with elsewhere • Hence the 90 day exclusion • Associations with different treatment patterns ANZDATA Registry, ANZSN 2003
Acknowledgements • All staff of contributing renal units • ANZDATA staff • Sheila Williams ANZDATA Registry, ANZSN 2003
www.anzdata.org.au ANZDATA Registry, ANZSN 2003